이상반응 보고
| VAERS ID | 2296234 |
|---|---|
| 성별 | 남성 |
| 나이 | 34세 |
| 주 코드 | FR |
| 제약회사 | JANSSEN |
| 로트 번호 | XE445 |
| 예방접종 횟수 | 1 |
| 접종일 | 2022-01-24 |
| 발병일 | 2022-01-24 |
| 상태 | 회복 |
증상
- 피로(Fatigue)
- 통증(Pain)
- 발기 부전(Erectile dysfunction)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
ERECTILE DISTURBANCE; GENERAL BODY PAIN; FATIGUE; This spontaneous report received from a health care professional via a Regulatory Authority, (Health Products Regulatory Authority) (ZA-SAHPRA-300064146) concerned a 34 year old male of an unspecified race and ethnicity.
The patient's height, and weight were not reported.
No past medical history or concurrent conditions were reported.
The patient received covid-19 vaccine ad26.
cov2.
s (suspension for injection, route of admin not reported, batch number: XE445 expiry: UNKNOWN) dose was not reported, first dose, 1 total administered on 24-JAN-2022 for an unspecified indication.
The age at time of vaccination was 34 years old.
No concomitant medications were reported.
On 24-JAN-2022, the patient experienced erectile disturbance, general body pain, and fatigue (no energy).
The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
The patient recovered from erectile disturbance, general body pain, and fatigue on 25-JAN-2022.
This report was serious (Other Medically Important Condition).
; Sender's Comments: V0: 20220545132-COVID-19 VACCINE AD26.
COV2.
S-erectile disturbance.
The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility.
There is no information on any other factors potentially associated with the event(s).
Therefore, this event(s) is considered unassessable.